Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.41 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.36 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23724 | 1.00 | ALDH1A1 (0.41) | ALDH1A1ALOX15GSTP1TAAR1SMN1; SMN2 | |
| SCHEMBL24784 | 0.78 | ALDH1A1 (0.36) | ALDH1A1ALOX15TAAR1SMN1; SMN2NPC1 | |
| SCHEMBL30603 | 0.78 | ALDH1A1 (0.36) | ALDH1A1ALOX15TAAR1SMN1; SMN2NPC1 | |
| SCHEMBL15128314 | 0.76 | PTPN1 (0.46) | ALDH1A1ALOX15TAAR1SMN1; SMN2NPC1 | |
| SCHEMBL27927911 | 0.76 | ALDH1A1 (0.39) | ALDH1A1ALOX15GSTP1TAAR1SMN1; SMN2 | |
| SCHEMBL722436 | 0.73 | ALDH1A1 (0.44) | ALDH1A1ALOX15TAAR1SMN1; SMN2NPC1 | |
| SCHEMBL11373811 | 0.73 | SMN1; SMN2 (0.46) | ALDH1A1ALOX15TAAR1SMN1; SMN2NPC1 | |
| SCHEMBL25212 | 0.73 | ALDH1A1 (0.41) | ALDH1A1ALOX15GSTP1TAAR1SMN1; SMN2 | |
| SCHEMBL25214 | 0.73 | ALDH1A1 (0.41) | ALDH1A1ALOX15GSTP1TAAR1SMN1; SMN2 | |
| SCHEMBL472103 | 0.70 | ALDH1A1 (0.47) | ALDH1A1ALOX15GSTP1SMN1; SMN2RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9845443-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2017-12-19 | — | — | US | disclosed |
| EP-2609184-B1 | PERFUMERY COMPOSITIONS AND SYNTHESIS OF A ODORANT | VAZE KEDAR RAMESH (IN) | 2017-02-15 | — | — | EP | disclosed |
| US-20160024424-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2016-01-28 | — | — | US | disclosed |
| US-9187709-B2 | Synthesis of a novel odorant | VAZE KEDAR RAMESH (IN) | 2015-11-17 | — | — | US | disclosed |
| EP-2609184-A1 | SYNTHESIS OF A NOVEL ODORANT | Vaze, Kedar Ramesh (IN) | 2013-07-03 | — | — | EP | disclosed |
| US-20130157923-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2013-06-20 | — | — | US | disclosed |
| WO-2012025934-A1 | SYNTHESIS OF A NOVEL ODORANT | VAZE KEDAR RAMESH (IN) | 2012-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160024424-A1 | SYNTHESIS OF A NOVEL ODORANT | OR10J3, OR51E2, TAS2R10 | ALDH1A1 1280/4885ALOX15 1505/4885GSTP1 3907/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.